Based on the results of this retrospective cohort study, pleural effusion, baseline CRP levels > 1.0 mg/dL, and use of steroids prior to treatment tended to reduce the effectiveness of first-line monotherapy with pembrolizumab. Here, CRP is linked to Pleural effusion.